Can Elevance Health's Value-Based Care Strategy Fuel Long-Term Growth?
ELV's focus on value-based care, Carelon integration and CareBridge acquisition drives membership and revenue growth.
UnitedHealth's Expansion Into ASCs: Redefining the Operating Room
UNH is expanding its Optum surgery centers, cutting costs while boosting growth and patient access in value-based care.
Elevance Shoots for the Stars But Lands at 3.5: $375M Bonus Gone?
Federal judge dismisses ELV's lawsuit challenging Medicare Advantage star ratings, leading to a $375M bonus loss tied to its star score.
CNC vs. HUM: Which Managed-Care Stock is a Smarter Investment?
Humana's strong Medicare Advantage growth and higher ROE give it an edge over Centene, which faces earnings pressure and OBBB Act headwinds.
UnitedHealth's Push Into Home Health: A New Growth Chapter?
UNH is expanding further into home health with Optum, fueled by a $3.3B Amedisys deal to boost value-based care growth.
CORRECTION - Bringing Advanced Vascular Diagnostics to the Western US with the SmartVascular Dx™ Test
IRVINE, Calif., Aug. 19, 2025 ( GLOBE NEWSWIRE ) -- MorningStar Laboratories, LLC., ( "MSL" or "the Company" ) , a leading developer of precision diagnostic tests that addresses unmet clinical needs, announced today corrections to the second paragraph of its press release under the same headline ...
Why Is UnitedHealth Group Stock Gaining Monday? - UnitedHealth Group ( NYSE:UNH )
BofA forecasts UnitedHealth earnings rebound by 2027, raising target to $325. The 2027 Medicare Advantage update and Star Ratings will shape profitability. See what Wall Street is buying with instant access to ratings on 1,000 top stocks, including Goldman Sachs, Morgan Stanley, and more.
Here's Why Humana ( HUM ) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Humana, DrFirst Ties Up to Boost Statin Use in High-Risk Patients
HUM partners with DrFirst to increase statin use in high-risk patients with diabetes and cardiovascular disease, aiming to close care gaps.
Is CNC Banking on Membership Growth to Boost Scale & Profitability?
Centene's growing membership base boosts revenue scale and operational efficiency, even as medical inflation puts pressure on margins.
SelectQuote ( SLQT ) Faces Investor Securities Class Action After Stock Dropped 19% Amid Department of Justice Alleges False Claims Act Violations - Hagens Berman - SelectQuote ( NYSE:SLQT )
SAN FRANCISCO, Aug. 12, 2025 ( GLOBE NEWSWIRE ) -- After investors in SelectQuote ( NYSE:SLQT ) saw the price of their shares tumble over 19% on May 1, 2025 when the U.S. Department of Justice announced it had intervened in a lawsuit against the company, a securities class action lawsuit, styled ...
Is the Market Bullish or Bearish on Humana? - Humana ( NYSE:HUM )
Humana's HUM short percent of float has risen 9.8% since its last report. The company recently reported that it has 4.68 million shares sold short, which is 4.37% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.93 days to cover their ...
Here's Why Humana ( HUM ) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Healthy Returns: Medicare, Medicaid will reportedly pilot covering obesity drugs - a potential win for drugmakers
The Trump administration is planning to pilot covering weight loss drugs. A longtime healthcare exec moves to a strategic advisory role at General Catalyst.
Centene Loses 57% YTD, Incurs Loss in Q2: How to Play the Stock
CNC plunges 57% YTD after its first quarterly loss in over a decade, with analysts slashing 2025 earnings outlook by 70%.
Why Humana ( HUM ) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
HUMANA ( HUM ) ALERT: Bragar Eagel & Squire, P.C. is Investigating Humana Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - Humana ( NYSE:HUM )
Bragar Eagel & Squire, P.C. Litigation Attorney Brandon Walker Encourages Investors Who Suffered Losses In Humana ( HUM ) To Contact Him Directly To Discuss Their Options
AMA: PBM Markets are at Risk of Harming Patients
CHICAGO, July 31, 2025 ( GLOBE NEWSWIRE ) -- The American Medical Association ( AMA ) today published a new annual analysis measuring competition in pharmacy benefit manager ( PBM ) markets and vertical integration of insurers with PBMs. The assessment demonstrates low competition in PBM markets ...
Humana ( HUM ) Q2 Revenue Rises 10%
Humana ( NYSE:HUM ) , one of the largest U.S. health insurers with a major focus on Medicare Advantage and integrated healthcare services, reported its second quarter 2025 results on July 30, 2025. The most notable headline was an adjusted earnings per share ( EPS ) of $6.27, and revenue of $32.4 ...
HUM Misses Q2 Earnings on Higher Benefit Costs, Ups '25 EPS View
Humana's Q2 earnings fall year over year on a declining membership base. Notably, 2025 adjusted EPS is currently forecasted at around $17.00, up from the earlier view of around $16.25.
Humana Boosts 2025 Profit Guidance, Plans $100 Million In Strategic Investments - Humana ( NYSE:HUM )
Q2 adjusted EPS of $6.27 beat estimates of $5.90 but fell from $6.96 last year. 2025 revenue forecast raised to at least $128 billion, above prior guidance and consensus. The market's back, and these 3 income stocks are thriving. See them here→
Humana ( HUM ) Q2 Earnings Lag Estimates
Humana (HUM) delivered earnings and revenue surprises of -0.79% and +1.93%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Curious about Humana ( HUM ) Q2 Performance? Explore Wall Street Estimates for Key Metrics
Besides Wall Street's top-and-bottom-line estimates for Humana (HUM), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025.
Can Humana Beat Q2 Earnings Estimates on Insurance Unit Strength?
HUM's second-quarter earnings are likely to have witnessed strength in insurance premiums and Medicare, partly offset by rising costs and membership declines.
Bulls And Bears: T-Mobile, LendingTree, Molina Healthcare - And Trade Deal Optimism Boosts Markets Bulls And Bears: T-Mobile, LendingTree, Molina Healthcare - And Trade Deal Optimism Boosts Markets - Cigna Group ( NYSE:CI ) , C3.ai ( NYSE:AI )
Benzinga examined the prospects for many investors' favorite stocks over the last week - here's a look at some of our top stories. Wall Street rallied as a wave of new trade deals - including agreements with Japan, Indonesia, and the Philippines - fueled optimism, pushing the S&P 500 and Nasdaq ...
UnitedHealthcare Pressure Builds: Trouble Ahead for UNH's Q2 Earnings?
UNH braces for a steep Q2 profit drop as soaring medical costs and DOJ scrutiny shake investor confidence.
Molina Healthcare Stumbles; Cigna, CVS And Humana Go With It - Molina Healthcare ( NYSE:MOH )
Molina reported Q2 EPS of $5.48, below estimates of $6.21; revenue beat at $11.43 billion vs. $10.93 billion. Molina cut 2025 EPS outlook to over $19, down from $21.50-$22.50; MCR forecast at 90.2% Up Next: Get 5 Dark Horse Stocks Wall Street Is Quietly Loading Up On Molina Healthcare Inc.
UnitedHealth on Thin Ice Before Q2 Earnings: Should Investors Exit?
UNH braces for a 27% earnings drop in Q2 as soaring medical costs, margin pressure and investor jitters weigh on performance.
Cigna ( CI ) Reports Next Week: Wall Street Expects Earnings Growth
Cigna (CI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Humana ( HUM ) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Humana (HUM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Humana Moves To Cut Prior Authorization Delays, Streamline Care Approvals - Sanofi ( NASDAQ:SNY )
Humana will eliminate one-third of prior authorizations for outpatient services by Jan. 1, 2026. 95% of complete electronic prior authorization requests will receive a decision within one business day by 2026.
Humana Shares Decline After Losing Medicare Bonus Payment Lawsuit: What To Know - Humana ( NYSE:HUM )
Humana shares dropped after losing a lawsuit over Medicare bonus payments, which could impact future profits. The company also faces broader scrutiny amid rising concerns about insurance claim denials across the industry.
CVS Health's Caremark to Lead CalPERS' PBM Vision: What's at Stake?
CVS wins a major CalPERS deal as Caremark replaces OptumRx, backed by $250M in performance guarantees and drug cost controls.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Humana ( HUM ) - technical analysis - Humana ( NYSE:HUM )
Shares of Humana ( HUM ) are oversold and close to support This could set the stage for a move higher. Up Next: Get 5 Dark Horse Stocks Wall Street Is Quietly Loading Up On Humana Inc. HUM is consolidating on Wednesday. But it may be about to reverse and rally.
Tivity Health Appoints Natasha Deckmann as CEO
NASHVILLE, Tenn., July 15, 2025 ( GLOBE NEWSWIRE ) -- Tivity Health, a leading provider of healthy lifestyle solutions, including SilverSneakers®, Prime® Fitness, and WholeHealth Living®, announced today that Natasha Deckmann, M.D., has been named Chief Executive Officer.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Longevity Health Surges 60% After Hours On Merger With THPlasma - Humana ( NYSE:HUM ) , Longevity Health Holdings ( NASDAQ:XAGE )
Longevity Health Holdings Inc. XAGE stock price surged by 59.92% in the after-hours trading session on Monday. What Happened: The stock price of Longevity Health Holdings saw an increase in the after-hours trading session, reaching $4.23.
Humana's Options: A Look at What the Big Money is Thinking - Humana ( NYSE:HUM )
Deep-pocketed investors have adopted a bearish approach towards Humana HUM, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.
UnitedHealth, Centene Hit Hard By Guidance Shock, Trump's Medicaid Push - Humana ( NYSE:HUM ) , Cigna Group ( NYSE:CI ) , Centene ( NYSE:CNC ) , Progressive ( NYSE:PGR )
UnitedHealth's market cap plunged 40.9% in Q2, but it remains the largest U.S. insurer at $283 billion. Centene shares crashed 40.37% on July 2 after it pulled 2025 guidance, sparking sector-wide declines. Get daily-updated rankings across momentum, growth, value, trends, and quality to spot the ...
UnitedHealth Under Fire as Medicaid & Centene Bombshell Rattle Sector
UNH and peers tumble as Medicaid cuts, enrollment shifts and rising costs shake up the managed care sector.
Humana Expands Medicaid Footprint With Virginia's Cardinal Care Win
Cardinal Care taps HUM to offer its Healthy Horizons Medicaid plan, unlocking new growth in Virginia's healthcare market.
Is Humana ( HUM ) a Great Value Stock Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
UnitedHealth Dropped From Russell Growth: How to Trade UNH Now
UNH's removal from key Russell growth indices caps a turbulent stretch marked by steep losses, rising costs and regulatory woes.
Zacks Industry Outlook Highlights Cigna, Humana, Centene and Molina Healthcare
CNC, MOH, CI, and HUM are set to benefit from Medicare demand, steady premiums, and tech-driven growth in the HMO space.
4 HMO Stocks Set to Thrive From Steady Premium Flows, M&A Strategy
Rising premiums, ongoing technological innovation and the growing demand for Medicare plans are anticipated to propel the performance of the Zacks Medical-HMO industry players. CI, HUM, CNC and MOH are poised to benefit from favorable industry prospects.
Is AI the Key to UnitedHealth's Market Growth and Cost Control?
UNH ramps up AI use to cut costs, boost efficiency, and reshape healthcare workflows, but legal risks remain.
Looking At Humana's Recent Unusual Options Activity - Humana ( NYSE:HUM )
Whales with a lot of money to spend have taken a noticeably bullish stance on Humana. Looking at options history for Humana HUM we detected 9 trades. If we consider the specifics of each trade, it is accurate to state that 55% of the investors opened trades with bullish expectations and 33% with ...
Major U.S. health insurers say they will streamline controversial process for approving care
Insurers such as CVS and UnitedHealthcare will implement the changes across commercial, Medicare and Medicaid plans, benefiting 257 million Americans.
Expanding Access in California: SmartVascular Dx™ Test Now Available Through Major Health Plans
IRVINE, Calif., June 19, 2025 ( GLOBE NEWSWIRE ) -- MorningStar Laboratories, LLC., ( "MSL" or "the Company" ) , a leading developer of precision diagnostic tests that address unmet clinical needs, is excited to announce that the SmartVascular Dx™ test ( formally known as the PULS™ Cardiac Test ...
